安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- FreeStyle Libre 3 in Diabetes Mellitus - Clinical Trials Registry - ICH GCP
This is a pivotal, non-randomized, single arm, multi-center, prospective, nonsignificant risk study to evaluate the FreeStyle Libre 3 Continuous Glucose Monitoring System accuracy and safety
- FreeStyle Libre | Clinical Studies and Real World Data
Two clinical studies, IMPACT and REPLACE, demonstrated that T1DM and T2DM FreeStyle Libre users safely and successfully replaced routine SMBG 28 FreeStyle Libre users monitored their glucose almost three times as frequently compared to self-monitored blood glucose (SMBG) 28
- FreeStyle Libre Clinical Evidence
The FreeStyle Libre portfolio helped reduce HbA1c *†1-13, hypoglycemia *†14-15, work absenteeism *†16-17, and resource utilization *†18-21, among patients with type 1 and type 2 diabetes See outcome categories below for further details
- Clinical Learnings | FreeStyle Libre Providers
Explore the clinical evidence behind continuous glucose monitors (CGMs) — the FreeStyle Libre systems Read clinical analyses, view clinical and real-world case studies, and watch helpful videos and webinars
- Clinical Evidence | Healthcare Professionals | Abbott
Discover the benefits of the FreeStyle Libre systems for a broad range of T1D and T2D patients based on clinical studies and evidence
- FreeStyle Libre Flash Glucose Monitoring System Accuracy Study
This is a pivotal, non-randomized, single arm, multi-center, prospective, non-significant risk study to evaluate the FreeStyle Libre Flash Glucose Monitoring System
- Real-World Evidence - FreeStyle Libre | Abbott
An independent study published in the New England Journal of Medicine3 shows that the FreeStyle Libre 2 system reduce HbA1c by 0 5% compared to self-monitored blood glucose (SMBG) at 6 months of use
- New Study Published in The New England Journal of . . . - Abbott MediaRoom
Randomized clinical trial of Abbott's FreeStyle Libre 2 system compared to self-monitoring of blood glucose (SMBG) shows FreeStyle Libre 2 leads to significant reductions in glycated hemoglobin (HbA1c) levels at 24 weeks in people with Type 1 diabetes and sub-optimal glycemic control 1
|
|
|